Jordan T R, Price J H, King K A, Masyk T, Bedell A W
Mercy Health Care Center, University of Toledo, Ohio 43624, USA.
Prev Med. 1999 Mar;28(3):297-303. doi: 10.1006/pmed.1998.0430.
Despite the high rate of prostate cancer screening, the accuracy of male patients' self-reports of screening has not been investigated. This study assessed the concordance between patients' self-reports of prostate screening and the medical record.
Focus groups were conducted to obtain male patients' perceptions of prostate cancer screening and salient terminology. A sample of males (n = 276), 40 years of age or older, completed a 15-item questionnaire. Patients' self-reports of PSA and DRE screening were then compared with medical records.
Results showed that patients' self-reports of DRE and PSA were discordant with the medical record 32 and 29% of the time, respectively. Sensitivity of patients' self-reports for DRE and PSA was 82 and 74%, respectively. Specificity of patients' self-reports for DRE and PSA was 56 and 65%, respectively. One in five patients reported that they were not sure how a doctor checks a man's prostate gland. Only 39% of patients knew that the prostate gland can be checked by a blood test.
There were significant differences between patients' self-reports and the medical record. The results should be of concern to primary care practitioners and to those who evaluate the efficacy of prostate cancer screening programs.
尽管前列腺癌筛查率很高,但男性患者筛查自我报告的准确性尚未得到研究。本研究评估了患者前列腺筛查自我报告与病历之间的一致性。
开展焦点小组以获取男性患者对前列腺癌筛查及突出术语的看法。抽取了276名40岁及以上的男性样本,完成一份包含15个条目的问卷。然后将患者前列腺特异性抗原(PSA)和直肠指检(DRE)筛查的自我报告与病历进行比较。
结果显示,患者DRE和PSA的自我报告分别有32%和29%的时间与病历不一致。患者DRE和PSA自我报告的敏感性分别为82%和74%。患者DRE和PSA自我报告的特异性分别为56%和65%。五分之一的患者表示不确定医生如何检查男性前列腺。只有39%的患者知道可以通过血液检查来检查前列腺。
患者的自我报告与病历之间存在显著差异。这些结果应引起初级保健从业者以及评估前列腺癌筛查项目疗效的人员的关注。